From May 12–14, we will be at the heart of the MAPS EMEA Annual Meeting 2025 in London. Our experts will be on-site at booth 26, joining industry leaders to exchange insights, tackle key challenges, and demonstrate how our cutting-edge Medical Affairs solutions are shaping the future of healthcare.
A key talking point in our presence this year is iON AI™, Inizio Medical’s proprietary platform built to transform Medical Affairs. iON AI™ is a powerhouse specifically designed to revolutionize Medical Affairs by connecting data across ecosystems, eliminating silos, and enabling the seamless integration of insights, strategy, and execution.
Our team will be showcasing how we’re reimagining Medical Affairs through our connected capabilities and deep expertise, bringing clarity, accelerating outcomes, and ultimately enhancing patient impact. Stop by booth 26 to explore how we:
- Harness the strength of thousands of experts working across the Medical Affairs spectrum.
- Collaborate closely to understand and solve your unique challenges.
- Simplify complexity to deliver actionable, insight-driven solutions.
Optimizing integration of acquisition products into your portfolio: Strategies for success
Rachel Hatfield, SVP, Medical Affairs, Medistrava, an Inizio Medical company
May 13 | 11:45 – 1:15pm BST
Breaking new ground: Collaborative efforts between Medical Affairs and commercial teams to improve patient and provider care
Shauna Aherne, President, Medical Excellence, Inizio Medical
May 13 | 11:45 – 1:15pm BST
Attending MAPS EMEA?
Book a meeting with our Medical Affairs experts at booth 26.
Jump to a slide with the slide dots.
Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series
Inizio Engage CEO Jim Sage shares leadership insights and perspectives on the future of pharma in pharmaphorum’s “12 Questions” interview.
Read moreInizio launches InConcert™ to transform pre-launch planning through connected intelligence.
Introducing InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase.
Read moreDelivering meaningful impact in hematology at the 2025 ASH® Annual Meeting.
Meet Inizio at ASH® 2025 to see how we turn hematology innovation into impact through science, strategy, and seamless execution.
Read more